Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of statement of stockholders??? equity

v3.21.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of statement of stockholders’ equity - USD ($)
3 Months Ended
Jun. 30, 2021
Mar. 31, 2021
As Reported [Member]    
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of statement of stockholders’ equity [Line Items]    
Sale of units in initial public offering, gross   $ 862,500,000
Offering costs   (47,036,560)
Sale of private placement warrants to Sponsor in private placement   19,250,000
Fair value of derivative warrant liabilities issued in initial public offering and private placement   (39,511,970)
Common stock subject to possible redemption $ 10,685,169 (785,037,090)
Accretion of Class A common stock to redemption amount  
Total stockholders’ equity (deficit) 5,000,001 5,000,004
Adjustment [Member]    
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of statement of stockholders’ equity [Line Items]    
Sale of units in initial public offering, gross   (862,500,000)
Offering costs   47,036,560
Sale of private placement warrants to Sponsor in private placement   (19,250,000)
Fair value of derivative warrant liabilities issued in initial public offering and private placement   39,511,970
Common stock subject to possible redemption (10,685,169) 785,037,090
Excess of cash received over fair value of the private placement warrants   4,491,670
Accretion of Class A common stock to redemption amount   (71,790,200)
Total stockholders’ equity (deficit) (88,148,079) (77,462,910)
As Restated [Member]    
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of statement of stockholders’ equity [Line Items]    
Sale of units in initial public offering, gross  
Offering costs  
Sale of private placement warrants to Sponsor in private placement  
Fair value of derivative warrant liabilities issued in initial public offering and private placement  
Common stock subject to possible redemption
Excess of cash received over fair value of the private placement warrants   4,491,670
Accretion of Class A common stock to redemption amount   (71,790,200)
Total stockholders’ equity (deficit) $ (83,148,078) $ (72,462,906)